SMMNY (SMMNY) Stock Price & Analysis
SMMNY (SMMNY) rose 2.63% to USD 20.26 as of June 10, 2026 at 03:39 UTC, according to Nexqual real-time market data.
SMMNY last closed at USD 19.74; the session ranged USD 20.1–20.28 on volume of 37,342 shares. Market capitalization is $45.35B, with a 52-week range of USD 19.32–28.92 (PNK). Source: Nexqual, June 10, 2026 at 03:39 UTC.
Key Statistics (as of June 10, 2026 at 03:39 UTC)
| Price | USD 20.26 |
|---|---|
| Change | ▲ 2.63% (up) |
| Previous Close | USD 19.74 |
| Open | USD 20.1 |
| Day Range | USD 20.1 – 20.28 |
| 52-Week Range | USD 19.32 – 28.92 |
| Volume | 37,342 shares |
| Market Cap | $45.35B |
| Exchange | PNK |
Technical Analysis (SMMNY)
Nexqual's technical model rates SMMNY "NEUTRAL" based on 2 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 03:39 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.29 (neutral) |
| vs SMA50 | Below (USD 20.66) |
| MACD | -0.18 (negative) |
Analyst Ratings (SMMNY)
Wall Street analysts rate SMMNY "Buy" based on 2 analysts, with a mean price target of USD 29.4 (range USD 21.8–37), per Nexqual as of June 10, 2026 at 03:39 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 29.4 |
| High Target | USD 37 |
| Low Target | USD 21.8 |
| Buy / Hold / Sell | 1 / 1 / 0 |
Earnings (SMMNY)
| Next Earnings Date | 2026-07-31 |
|---|---|
| Revenue Estimate | $5.86B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-09-30 | USD 0.39 vs est 0.43 ▼ miss |
| 2025-06-30 | USD 0.37 vs est 0.32 ▲ beat |
Source: Nexqual, June 10, 2026 at 03:39 UTC.
Financials & Fundamentals (SMMNY)
| Total Revenue | $23.07B |
|---|---|
| Revenue Growth (YoY) | -3.90% |
| Gross Margin | +38.03% |
| Operating Margin | +12.75% |
| Profit Margin | +9.08% |
| ROE | +11.47% |
| Debt / Equity | 83.88 |
| Current Ratio | 1.1 |
| Total Cash | $1.91B |
| Total Debt | $15.32B |
| Free Cash Flow | $2.49B |
Source: Nexqual, June 10, 2026 at 03:39 UTC.
Financial Health Score (SMMNY)
Nexqual rates SMMNY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:39 UTC.
| Growth | Mixed — Revenue +4.5% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 38%, operating 13% |
| Balance Sheet | Mixed — $1.91B cash vs $15.3B debt |
| Cash Flow | Solid — FCF $2.49B, 11% margin |
| Efficiency | Mixed — ROE 11%, ROA 4.1% |
Ownership (SMMNY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.24B |
| Float | 356.40M |
Source: Nexqual, June 10, 2026 at 03:39 UTC.
Leadership (SMMNY)
SMMNY is led by Bernhard Montag (age 56), President, CEO & Chairman of Management Board, per Nexqual as of June 10, 2026 at 03:39 UTC.
| President, CEO & Chairman of Management Board | Bernhard Montag (age 56) |
|---|---|
| CFO & Member of Management Board | Jochen Schmitz (age 59) |
| Chief Human Resources Officer, Labor Director & Member of Management Board | Darleen Caron (age 61) |
| Executive Vice President of Finance | Christian Klaussner |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MKKGY | Merck KGaA | USD 32 | ▲ 2.11% |
| CSLLY | CSL Ltd. | USD 17.44 | ▲ 1.87% |
| SEMHF | SIEMENS HEALTHINEERS AG | USD 40.5 | ▲ 4.82% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22.85 | ▼ 0.91% |
| ESLOY | EssilorLuxottica | USD 103.88 | ▲ 4.6% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:39 UTC. This page is informational and not investment advice.